Aiding Cancer’s “Sweet Tooth”: Role of Hexokinases in Metabolic Reprogramming
Authors:
- Zeenat FarooqZFZeenat Farooq
- Hagar IsmailHIHagar Ismail
- Sheraz BhatSBSheraz Bhat
- Brian LaydenBLBrian Layden
- Wasim KhanWasim Khan
Preprint
- 27 March 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Hexokinases (HKs) convert hexose sugars to hexose-6-phosphate, thus trapping them inside cells to meet the synthetic and energetic demands. HKs participate in various standard and altered physiological processes, including cancer, primarily through the reprogramming of cellular metabolism. Four canonical HKs have been identified with different expression patterns across tissues. HKs 1-3 play a role in glucose utilization, whereas HK 4 (glucokinase, GCK) also acts as a glucose sensor. Recently, a novel 5th HK, hexokinase domain containing 1 (HKDC1), has been identified, which plays a role in whole-body glucose utilization and insulin sensitivity. Beyond the metabolic functions, HKDC1 is differentially expressed in many forms of human cancer. This review focuses on the role of HKs, particularly HKDC1, in metabolic reprogramming and cancer progression.Keywords
All Related Versions
- Version 1, 2023-03-27, Preprints
- Published version: Life, 13 (4), 946.